Trial Profile
Trachoma Elimination Study by Focused Antibiotic (TESFA): The Impact of an Enhanced Antibiotic Treatment Regimen on Trachoma in Amhara, Ethiopia
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2023
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Trachoma
- Focus Therapeutic Use
- Acronyms TESFA
- 12 Oct 2023 Planned End Date changed from 1 Sep 2025 to 1 Apr 2026.
- 12 Oct 2023 Planned primary completion date changed from 1 Sep 2024 to 1 Apr 2025.
- 01 May 2023 Planned End Date changed from 1 May 2025 to 1 Sep 2025.